Literature DB >> 9230223

A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996.

J M Gallo, U Hafeli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9230223

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

2.  Citric-acid-coated magnetite nanoparticles for biological applications.

Authors:  M Răcuciu; D E Creangă; A Airinei
Journal:  Eur Phys J E Soft Matter       Date:  2006-11-27       Impact factor: 1.890

Review 3.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

Review 4.  Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.

Authors:  P Stephen Williams; Francesca Carpino; Maciej Zborowski
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

5.  Evaluation of magnetic micro- and nanoparticle toxicity to ocular tissues.

Authors:  Hemalatha B Raju; Ying Hu; Anil Vedula; Sander R Dubovy; Jeffrey L Goldberg
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

6.  Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres.

Authors:  Hong Zhao; Jeffrey Gagnon; Urs O Häfeli
Journal:  Biomagn Res Technol       Date:  2007-04-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.